CR
Crane Rosemary A
Director
BoardF
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Crane Rosemary A, Director. Officer active across 4 companies, notably Teva Pharmaceutical Industries Ltd. Aggregated, 16 filings have been recorded. Activity tracked since 28 October 2021. The latest transaction was disclosed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Crane Rosemary A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
14,492 sharesOrdinary SharesSEC:0001193125-26-261706:0
15,757 shares0Common StockSEC:0001443343-26-000003:0
9,632 sharesOrdinary SharesSEC:0000950170-25-083724:0
11,928 shares0Common StockSEC:0001415889-25-014190:0
3,350 sharesCommon StockSEC:0001819790-24-000104:0
21,108 sharesOrdinary SharesSEC:0000950170-24-074022:0
8,663 shares0Common StockSEC:0001415889-24-014283:0
6,993 shares0Common StockSEC:0001596783-23-000155:0
15,810 sharesOrdinary SharesSEC:0001209191-23-044772:0
2,000 sharesCommon StockSEC:0001819790-23-000046:0
9,324 shares0Common StockSEC:0001415889-23-008750:0
4,149 shares0Common StockSEC:0001596783-22-000167:0
14,479 sharesOrdinary SharesSEC:0001209191-22-037245:0
1,402 shares0Common StockSEC:0001596783-21-000171:0
12,668 sharesOrdinary SharesSEC:0001209191-21-039368:0
6,041 sharesOrdinary SharesSEC:0001209191-21-038820:0
About Crane Rosemary A
Crane Rosemary A is Administrateur and has filed 16 disclosures in total. In the 16 sampled disclosures, the most frequent transaction nature is option exercise, with dates ranging from 2021-06-08 to 2026-06-08. Filings were reported for Teva Pharmaceutical Industries Ltd, Certara, Inc., Catalent, Inc. and Tarsus Pharmaceuticals, Inc.